{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T02:55:17Z","timestamp":1783565717778,"version":"3.55.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-06566-w","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:38:33Z","timestamp":1751431113000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Exploring the molecular mechanisms of comorbidity between thyroid cancer and breast cancer through multi-omics data"],"prefix":"10.1038","volume":"15","author":[{"given":"Rui","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"issue":"1","key":"6566_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel, R. L. et al. Cancer statistics, 2025 [J]. CA Cancer J. Clin. 75(1), 10\u201345 (2025).","journal-title":"CA Cancer J. Clin."},{"issue":"10476","key":"6566_CR2","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S0140-6736(24)02715-6","volume":"405","author":"JA Dunn","year":"2025","unstructured":"Dunn, J. A. et al. Annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years and older in the UK (Mammo-50): a multicentre, randomised, phase 3, non-inferiority trial [J]. Lancet 405(10476), 396\u2013407 (2025).","journal-title":"Lancet"},{"issue":"5","key":"6566_CR3","first-page":"425","volume":"331","author":"L Boucai","year":"2024","unstructured":"Boucai, L., Zafereo, M. & Cabanillas, M. E. Thyroid Cancer: Rev. [J] Jama 331(5), 425\u2013435 (2024).","journal-title":"Thyroid Cancer: Rev. [J] Jama"},{"key":"6566_CR4","first-page":"153","volume":"15","author":"GT Beatson","year":"1896","unstructured":"Beatson, G. T. On the Treatment of Inoperable Cases of Carcinoma of the Mamma: Suggestions for a New Method of Treatment, with Illustrative Cases [J]. Trans. Med. Chir. Soc. Edinb. 15, 153\u2013179 (1896).","journal-title":"Trans. Med. Chir. Soc. Edinb."},{"issue":"1","key":"6566_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1349-7006.2001.tb01040.x","volume":"92","author":"H Tanaka","year":"2001","unstructured":"Tanaka, H. et al. Second primary cancers following breast cancer in the Japanese female population [J]. Jpn J. Cancer Res. 92(1), 1\u20138 (2001).","journal-title":"Jpn J. Cancer Res."},{"issue":"12","key":"6566_CR6","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1089\/thy.2014.0561","volume":"25","author":"JH An","year":"2015","unstructured":"An, J. H. et al. A possible association between thyroid Cancer and breast Cancer [J]. Thyroid 25(12), 1330\u20131338 (2015).","journal-title":"Thyroid"},{"issue":"1","key":"6566_CR7","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1186\/s12889-019-7947-y","volume":"19","author":"S Li","year":"2019","unstructured":"Li, S. et al. Clinicopathological features, survival and risk in breast cancer survivors with thyroid cancer: an analysis of the SEER database [J]. BMC Public. Health 19(1), 1592 (2019).","journal-title":"BMC Public. Health"},{"key":"6566_CR8","doi-asserted-by":"crossref","unstructured":"Halada, S. et al. Hormonal Crosstalk between Thyroid Breast Cancer [J] Endocrinol., 163(7). (2022).","DOI":"10.1210\/endocr\/bqac075"},{"key":"6566_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/bs.apcsb.2019.01.001","volume":"116","author":"Fuentes N, Silveyra P","year":"2019","unstructured":"Fuentes N, Silveyra P. Estrogen receptor signaling mechanisms [J]. Adv. Protein Chem. Struct. Biol. 116, 135\u2013170 (2019).","journal-title":"Adv. Protein Chem. Struct. Biol."},{"issue":"3","key":"6566_CR10","first-page":"1","volume":"62","author":"D Meng","year":"2016","unstructured":"Meng, D. et al. MicroRNA-1280 modulates cell growth and invasion of thyroid carcinoma through targeting Estrogen receptor \u03b1 [J]. Cell. Mol. Biol. (Noisy-le-grand) 62(3), 1\u20136 (2016).","journal-title":"Cell. Mol. Biol. (Noisy-le-grand)"},{"key":"6566_CR11","doi-asserted-by":"publisher","first-page":"593479","DOI":"10.3389\/fonc.2021.593479","volume":"11","author":"J Liu","year":"2021","unstructured":"Liu, J. & Xu, T. Signal pathway of Estrogen and Estrogen receptor in the development of thyroid Cancer [J]. Front. Oncol. 11, 593479 (2021).","journal-title":"Front. Oncol."},{"issue":"1","key":"6566_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s12672-016-0280-3","volume":"8","author":"M I Flamini","year":"2017","unstructured":"Flamini, M. I. et al. Thyroid hormone controls breast Cancer cell movement. Horm. Cancer 8(1), 16\u201327 (2017).","journal-title":"Horm. Cancer"},{"key":"6566_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11030687","author":"Voutsadakis I. A","year":"2022","unstructured":"Voutsadakis I. A. The TSH\/Thyroid Hormones Axis and Breast Cancer [J]. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm11030687 (2022).","journal-title":"J. Clin. Med."},{"key":"6566_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14205117","author":"M Lu","year":"2022","unstructured":"Lu, M. et al. Links between Breast and Thyroid Cancer: Hormones, Genetic Susceptibility and Medical Interventions [J]. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers14205117 (2022).","journal-title":"Cancers (Basel)"},{"issue":"1","key":"6566_CR15","doi-asserted-by":"publisher","first-page":"15578","DOI":"10.1038\/s41598-024-66162-2","volume":"14","author":"H Jiang","year":"2024","unstructured":"Jiang, H. et al. Identification and validation of potential common biomarkers for papillary thyroid carcinoma and hashimoto\u2019s thyroiditis through bioinformatics analysis and machine learning [J]. Sci. Rep. 14(1), 15578 (2024).","journal-title":"Sci. Rep."},{"issue":"1","key":"6566_CR16","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s12967-023-04218-z","volume":"21","author":"J Zhu","year":"2023","unstructured":"Zhu, J. et al. Exploring the molecular mechanism of comorbidity of autism spectrum disorder and inflammatory bowel disease by combining multiple data sets [J]. J. Transl Med. 21(1), 372 (2023).","journal-title":"J. Transl Med."},{"issue":"1","key":"6566_CR17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s10020-024-00851-6","volume":"30","author":"Z Nian","year":"2024","unstructured":"Nian, Z. et al. Multi-omics analysis uncovered systemic lupus erythematosus and COVID-19 crosstalk [J]. Mol. Med. 30(1), 81 (2024).","journal-title":"Mol. Med."},{"issue":"52","key":"6566_CR18","doi-asserted-by":"publisher","first-page":"19075","DOI":"10.1073\/pnas.0509603102","volume":"102","author":"H He","year":"2005","unstructured":"He, H. et al. The role of MicroRNA genes in papillary thyroid carcinoma [J]. Proc. Natl. Acad. Sci. U S A 102(52), 19075\u201319080 (2005).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"34","key":"6566_CR19","doi-asserted-by":"publisher","first-page":"36652","DOI":"10.18632\/oncotarget.5543","volume":"6","author":"L Aswad","year":"2015","unstructured":"Aswad, L. et al. Genome and transcriptome delineation of two major oncogenic pathways governing invasive ductal breast cancer development [J]. Oncotarget 6(34), 36652\u201336674 (2015).","journal-title":"Oncotarget"},{"issue":"D1","key":"6566_CR20","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa, M. et al. KEGG: new perspectives on genomes, pathways, diseases and drugs [J]. Nucleic Acids Res. 45(D1), D353-d61 (2017).","journal-title":"Nucleic Acids Res."},{"key":"6566_CR21","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder, P. WGCNA: an R package for weighted correlation network analysis [J]. BMC Bioinform. 9, 559 (2008).","journal-title":"BMC Bioinform."},{"issue":"11","key":"6566_CR22","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks [J]. Genome Res. 13(11), 2498\u20132504 (2003).","journal-title":"Genome Res."},{"issue":"10","key":"6566_CR23","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1038\/psp.2013.56","volume":"2","author":"K Ito","year":"2013","unstructured":"Ito, K. Application of ggplot2 to pharmacometric graphics [J]. CPT Pharmacometrics Syst. Pharmacol. 2(10), e79 (2013).","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"6566_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/cpbi.5","author":"G Stelzer","year":"2016","unstructured":"Stelzer, G. et al. The genecards suite: from gene data mining to disease genome sequence analyses [J]. Curr Protoc Bioinformatics https:\/\/doi.org\/10.1002\/cpbi.5 (2016).","journal-title":"Curr Protoc Bioinformatics"},{"issue":"15","key":"6566_CR25","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1093\/bioinformatics\/bts344","volume":"28","author":"A Jeggari","year":"2012","unstructured":"Jeggari, A., Marks, D. S., Larsson E. MiRcode: a map of putative MicroRNA target sites in the long non-coding transcriptome [J]. Bioinformatics 28(15), 2062\u20132063 (2012).","journal-title":"Bioinformatics"},{"issue":"D1","key":"6566_CR26","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M. et al. KEGG: biological systems database as a model of the real world [J]. Nucleic Acids Res. 53(D1), D672-d7 (2025).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"6566_CR27","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"Kanehisa M","year":"2019","unstructured":"Kanehisa M. Toward Understanding the origin and evolution of cellular organisms [J]. Protein Sci. 28(11), 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"issue":"1","key":"6566_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes [J]. Nucleic Acids Res. 28(1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"6566_CR29","doi-asserted-by":"publisher","first-page":"6393","DOI":"10.1002\/cam4.1856","volume":"7","author":"N S Huang","year":"2018","unstructured":"Huang, N. S. et al. Association between breast cancer and thyroid cancer: A study based on 13 978 patients with breast cancer [J]. Cancer Med. 7(12), 6393\u20136400 (2018).","journal-title":"Cancer Med."},{"issue":"728","key":"6566_CR30","doi-asserted-by":"publisher","first-page":"eadg3840","DOI":"10.1126\/scitranslmed.adg3840","volume":"16","author":"J J F Sleeboom","year":"2024","unstructured":"Sleeboom, J. J. F. et al. The extracellular matrix as hallmark of cancer and metastasis: from biomechanics to therapeutic targets [J]. Sci. Transl Med. 16(728), eadg3840 (2024).","journal-title":"Sci. Transl Med."},{"issue":"8","key":"6566_CR31","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41580-019-0134-2","volume":"20","author":"JZ Kechagia","year":"2019","unstructured":"Kechagia, J. Z., Ivaska, J. & Roca-Cusachs, P. Integrins as Biomechanical sensors of the microenvironment [J]. Nat. Rev. Mol. Cell. Biol. 20(8), 457\u2013473 (2019).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"6566_CR32","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.173712","author":"PZ Han","year":"2024","unstructured":"Han, P. Z. et al. A distinct tumor microenvironment makes anaplastic thyroid cancer more lethal but immunotherapy sensitive than papillary thyroid cancer [J]. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.173712 (2024).","journal-title":"JCI Insight"},{"key":"6566_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49824-7","author":"Y Hou","year":"2024","unstructured":"Hou, Y. et al. The neurotransmitter calcitonin gene-related peptide shapes an immunosuppressive microenvironment in medullary thyroid cancer [J]. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-024-49824-7 (2024).","journal-title":"Nat. Commun."},{"issue":"8","key":"6566_CR34","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/s41568-024-00714-6","volume":"24","author":"MA Harris","year":"2024","unstructured":"Harris, M. A. & Savas, P. Towards targeting the breast cancer immune microenvironment [J]. Nat. Rev. Cancer 24(8), 554\u2013577 (2024).","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"6566_CR35","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41392-020-00453-8","volume":"6","author":"Q Li","year":"2021","unstructured":"Li, Q. et al. HIF-1\u03b1-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation [J]. Signal. Transduct. Target. Ther. 6(1), 76 (2021).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"2","key":"6566_CR36","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.celrep.2019.03.037","volume":"27","author":"L Devorkin","year":"2019","unstructured":"Devorkin, L. et al. Autophagy Regulation of Metabolism Is Required for CD8(+) T Cell Anti-tumor Immunity [J]. Cell. Rep. 27(2), 502-513.e5 (2019).","journal-title":"Cell. Rep."},{"issue":"7","key":"6566_CR37","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrg1379","volume":"5","author":"HEL Hannon","year":"2004","unstructured":"Hannon, H. E. L. MicroRNAs: small RNAs with a big role in gene regulation [J]. Nat. Rev. Genet. 5(7), 522\u2013531 (2004).","journal-title":"Nat. Rev. Genet."},{"issue":"1","key":"6566_CR38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13058-023-01690-9","volume":"25","author":"NG Martinez-Illescas","year":"2023","unstructured":"Martinez-Illescas, N. G. et al. miR-203 drives breast cancer cell differentiation [J]. Breast Cancer Res. 25(1), 91 (2023).","journal-title":"Breast Cancer Res."},{"key":"6566_CR39","doi-asserted-by":"publisher","first-page":"6203","DOI":"10.2147\/OTT.S108712","volume":"9","author":"S He","year":"2016","unstructured":"He, S. et al. miR-203 facilitates tumor growth and metastasis by targeting fibroblast growth factor 2 in breast cancer [J]. Onco Targets Ther. 9, 6203\u20136210 (2016).","journal-title":"Onco Targets Ther."},{"key":"6566_CR40","first-page":"631","volume":"16","author":"X Yang","year":"2024","unstructured":"Yang, X. et al. Plasma exosome miR-203a-3p is a potential liquid biopsy marker for assessing tumor progression in breast Cancer patients [J]. Breast Cancer (Dove Med. Press) 16, 631\u2013643 (2024).","journal-title":"Breast Cancer (Dove Med. Press)"},{"issue":"6","key":"6566_CR41","doi-asserted-by":"publisher","first-page":"e24470","DOI":"10.1002\/jcla.24470","volume":"36","author":"L Dai","year":"2022","unstructured":"Dai, L. et al. MicroRNA-203a-3p May prevent the development of thyroid papillary carcinoma via repressing MAP3K1 and activating autophagy [J]. J. Clin. Lab. Anal. 36(6), e24470 (2022).","journal-title":"J. Clin. Lab. Anal."},{"issue":"7","key":"6566_CR42","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1002\/tox.23791","volume":"38","author":"Y Shi","year":"2023","unstructured":"Shi, Y. et al. The estrogen\/miR-338-3p\/ADAM17 axis enhances the viability of breast cancer cells via suppressing NK cell\u2019s function [J]. Environ. Toxicol. 38(7), 1618\u20131627 (2023).","journal-title":"Environ. Toxicol."},{"issue":"11","key":"6566_CR43","first-page":"1747","volume":"32","author":"YE Zhang","year":"2024","unstructured":"Zhang, Y. E. et al. CircTIAM1 overexpression promotes the progression of papillary thyroid cancer by regulating the miR-338-3p\/LASP1 axis [J]. Oncol. Res. 32(11), 1747\u20131763 (2024).","journal-title":"Oncol. Res."},{"issue":"8","key":"6566_CR44","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/abbs\/gmz067","volume":"51","author":"L Min","year":"2019","unstructured":"Min, L. et al. miR-214 inhibits epithelial-mesenchymal transition of breast cancer cells via downregulation of RNF8 [J]. Acta Biochim. Biophys. Sin (Shanghai) 51(8), 791\u2013798 (2019).","journal-title":"Acta Biochim. Biophys. Sin (Shanghai)"},{"issue":"6","key":"6566_CR45","first-page":"3027","volume":"42","author":"F Liu","year":"2018","unstructured":"Liu, F. et al. miR-214 regulates papillary thyroid carcinoma cell proliferation and metastasis by targeting PSMD10 [J]. Int. J. Mol. Med. 42(6), 3027\u20133036 (2018).","journal-title":"Int. J. Mol. Med."},{"issue":"6","key":"6566_CR46","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.7150\/jca.90457","volume":"15","author":"IM Lambrescu","year":"2024","unstructured":"Lambrescu, I. M. et al. Inside anticancer therapy resistance and metastasis. Focus on CD36 [J]. J. Cancer 15(6), 1675\u20131686 (2024).","journal-title":"J. Cancer"},{"key":"6566_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2025.03.036","author":"Z Wang","year":"2025","unstructured":"Wang, Z. et al. CD36-mediated endocytosis of proteolysis-targeting chimeras [J]. Cell https:\/\/doi.org\/10.1016\/j.cell.2025.03.036 (2025).","journal-title":"Cell"},{"issue":"1","key":"6566_CR48","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.mce.2009.10.016","volume":"321","author":"M Saji","year":"2010","unstructured":"Saji, M. & Ringel, M. D. The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors [J]. Mol. Cell. Endocrinol. 321(1), 20\u201328 (2010).","journal-title":"Mol. Cell. Endocrinol."},{"key":"6566_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010173","author":"D Miricescu","year":"2020","unstructured":"Miricescu, D. et al. PI3K\/AKT\/mTOR signaling pathway in breast cancer: from molecular landscape to clinical aspects [J]. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms22010173 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"5844","key":"6566_CR50","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/bmj.1.5844.13","volume":"1","author":"Ward H. W","year":"1973","unstructured":"Ward H. W. Anti-oestrogen therapy for breast cancer: a trial of Tamoxifen at two dose levels [J]. Br. Med. J. 1(5844), 13\u201314 (1973).","journal-title":"Br. Med. J."},{"issue":"1","key":"6566_CR51","first-page":"308","volume":"80","author":"T Hoelting","year":"1995","unstructured":"Hoelting, T. et al. Tamoxifen inhibits growth, migration, and invasion of human follicular and papillary thyroid cancer cells in vitro and in vivo [J]. J. Clin. Endocrinol. Metab. 80(1), 308\u2013313 (1995).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"6566_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/cells9122636","author":"S-I Hayashi","year":"2020","unstructured":"Hayashi, S.-I. Insight into the Role of Angiopoietins in Ageing-Associated Diseases [J]. Cells https:\/\/doi.org\/10.3390\/cells9122636 (2020).","journal-title":"Cells"},{"key":"6566_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2014.00004","author":"G Santulli","year":"2014","unstructured":"Santulli, G. Angiopoietin-like proteins: a comprehensive look [J]. Front. Endocrinol. (Lausanne) https:\/\/doi.org\/10.3389\/fendo.2014.00004 (2014).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"6566_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19020431","author":"C Carbone","year":"2018","unstructured":"Carbone, C. et al. Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer [J]. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms19020431 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"6566_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/cells9020457","author":"X Yu","year":"2020","unstructured":"Yu, X. & Ye, F. Role of angiopoietins in development of cancer and neoplasia associated with viral infection [J]. Cells https:\/\/doi.org\/10.3390\/cells9020457 (2020).","journal-title":"Cells"},{"issue":"3","key":"6566_CR56","doi-asserted-by":"publisher","first-page":"317","DOI":"10.7888\/juoeh.41.317","volume":"41","author":"Endo M","year":"2019","unstructured":"Endo M. The roles of ANGPTL families in Cancer progression [J]. J. Uoeh 41(3), 317\u2013325 (2019).","journal-title":"J. Uoeh"},{"issue":"1","key":"6566_CR57","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1172\/JCI91882","volume":"127","author":"TC Kuo","year":"2017","unstructured":"Kuo, T. C. et al. Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility [J]. J. Clin. Invest. 127(1), 402 (2017).","journal-title":"J. Clin. Invest."},{"issue":"5","key":"6566_CR58","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1002\/hep.28773","volume":"64","author":"HA Chen","year":"2016","unstructured":"Chen, H. A. et al. Angiopoietin-like protein 1 antagonizes MET receptor activity to repress Sorafenib resistance and cancer stemness in hepatocellular carcinoma [J]. Hepatology 64(5), 1637\u20131651 (2016).","journal-title":"Hepatology"},{"issue":"1","key":"6566_CR59","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10616-018-0259-8","volume":"71","author":"H Fan","year":"2019","unstructured":"Fan, H. et al. Angiopoietin-like protein 1 inhibits epithelial to mesenchymal transition in colorectal cancer cells via suppress slug expression [J]. Cytotechnology 71(1), 35\u201344 (2019).","journal-title":"Cytotechnology"},{"issue":"5","key":"6566_CR60","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3892\/ol.2020.12103","volume":"20","author":"R Sun","year":"2020","unstructured":"Sun, R. et al. ANGPTL1 is a potential biomarker for differentiated thyroid cancer diagnosis and recurrence [J]. Oncol. Lett. 20(5), 240 (2020).","journal-title":"Oncol. Lett."},{"key":"6566_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/cells10102590","author":"H Yang","year":"2021","unstructured":"Yang, H. et al. Distinct clinical impact and biological function of angiopoietin and angiopoietin-like proteins in human breast cancer [J]. Cells https:\/\/doi.org\/10.3390\/cells10102590 (2021).","journal-title":"Cells"},{"issue":"6","key":"6566_CR62","first-page":"1421","volume":"53","author":"P Clezardin","year":"1993","unstructured":"Clezardin, P. et al. Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast [J]. Cancer Res. 53(6), 1421\u20131430 (1993).","journal-title":"Cancer Res."},{"issue":"1","key":"6566_CR63","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.canlet.2003.10.021","volume":"207","author":"IP Uray","year":"2004","unstructured":"Uray, I. P., Liang, Y. & Hyder, S. M. Estradiol down-regulates CD36 expression in human breast cancer cells [J]. Cancer Lett. 207(1), 101\u2013107 (2004).","journal-title":"Cancer Lett."},{"issue":"7","key":"6566_CR64","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1002\/stem.1716","volume":"32","author":"JS Hale","year":"2014","unstructured":"Hale, J. S. et al. Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression [J]. Stem Cells 32(7), 1746\u20131758 (2014).","journal-title":"Stem Cells"},{"issue":"7635","key":"6566_CR65","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nature20791","volume":"541","author":"G Pascual","year":"2017","unstructured":"Pascual, G. et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36 [J]. Nature 541(7635), 41\u201345 (2017).","journal-title":"Nature"},{"issue":"1","key":"6566_CR66","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1186\/s12864-023-09854-9","volume":"24","author":"H Wang","year":"2023","unstructured":"Wang, H. et al. Unbalanced bidirectional causal association between thyroid cancer and ER-positive breast cancer: should we recommend screening for thyroid cancer in breast cancer patients? [J]. BMC Genom. 24(1), 762 (2023).","journal-title":"BMC Genom."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06566-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06566-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06566-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T06:16:58Z","timestamp":1751437018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06566-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6566"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-06566-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"22 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethics approval and consent to participate were waived since we used only publicly available data and materials in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"23309"}}